Device recall · April 23, 2025
t:slim X2 Insulin Pump with Interoperable Technology recall
Why: A software defect in Version 7.9 of the pump software for Tandem t:slim X2 and Tandem Mobi pumps, when used with Control IQ+ technology, will cause the pump to incorrectly interpolate glucose trends when the Estimated Glucose Value (EGV) is above 255 mg/dL at the start or end of a gap in data collection due to a lapse in connection from a paired continuous glucose monitor (CGM) sensor, which can lead to under-delivery or over-delivery of insulin based on inaccurate result leading to severe cases of hypoglycemia or hyperglycemia.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
t:slim X2 Insulin Pump with Interoperable Technology
- Lots / codes
Software versions 7.9/UDI: 00389152407012
- Quantity
- 63 units
- Company
- Tandem Diabetes Care, Inc., San Diego, CA
- Distribution
- US: AZ, CA, CO, CT, FL, HI, IA, ID, IL, IN, MD, ME, MI, MO, MS, NC, ND, NE, NJ, NM, NV, NY, OH, PA, TX, UT, VA, WA, WI OUS: N/A
- Initiated
- February 27, 2025 · Voluntary: Firm initiated
- Classified
- April 11, 2025
- Reported
- April 23, 2025
- How notified
- Telephone
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.